Biodistribution of Oncolytic Measles Virus after Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice

Kah-Whye Peng, Marie Frenzke, Rae Myers, Diane Soeffker, Mary Harvey, Suzanne Greiner, Evanthia Galanis, Roberto Cattaneo, Mark J Federspiel, Stephen J Russell

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

In support of a proposed phase I clinical trial, we studied the biodistribution of virus-infected cells after intraperitoneal administration of oncolytic measles viruses to alpha/beta interferon-defective mice expressing human CD46 with human-like tissue specificity. Various marker genes were employed, and green fluorescent protein proved to be most informative. Mesothelium and ovarian surface epithelium were remarkably resistant to infection, but infected peritoneal macrophages were present in abundance both in peritoneal lavage fluid and in the greater omentum, where they were heavily concentrated in "milky spots". Infected macrophages were also identified outside the peritoneal cavity, along the peritoneal fluid drainage pathway and in the spleen. Thus, diaphragmatic stomata, thoracic lymphatic vessels, and parathymic lymph nodes contained numerous measles-infected cells, as did the marginal zones of the white pulp of the spleen. Splenic marginal zone macrophages were the predominant targets of infection after intravenous administration of oncolytic measles viruses. When measles-infected peritoneal macrophages were adoptively transferred, they did not migrate beyond the confines of the peritoneal cavity, suggesting that, after intraperitoneal virus administration, the positive cells in thoracic lymphatics, parathymic lymph nodes, and spleen are nonmigratory cells transduced in situ by viral particles that have exited from the peritoneal cavity.

Original languageEnglish (US)
Pages (from-to)1565-1577
Number of pages13
JournalHuman Gene Therapy
Volume14
Issue number16
DOIs
StatePublished - Nov 1 2003

Fingerprint

Oncolytic Viruses
Measles virus
Transgenic Mice
Peritoneal Cavity
Spleen
Ascitic Fluid
Measles
Peritoneal Macrophages
Peritoneal Stomata
Thorax
Epithelium
Lymph Nodes
Macrophages
Viruses
Peritoneal Lavage
Organ Specificity
Clinical Trials, Phase I
Omentum
Lymphatic Vessels
Interferon-beta

ASJC Scopus subject areas

  • Genetics

Cite this

Biodistribution of Oncolytic Measles Virus after Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice. / Peng, Kah-Whye; Frenzke, Marie; Myers, Rae; Soeffker, Diane; Harvey, Mary; Greiner, Suzanne; Galanis, Evanthia; Cattaneo, Roberto; Federspiel, Mark J; Russell, Stephen J.

In: Human Gene Therapy, Vol. 14, No. 16, 01.11.2003, p. 1565-1577.

Research output: Contribution to journalArticle

@article{25bde7e1505d47a6a424cf59bc5f2c4b,
title = "Biodistribution of Oncolytic Measles Virus after Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice",
abstract = "In support of a proposed phase I clinical trial, we studied the biodistribution of virus-infected cells after intraperitoneal administration of oncolytic measles viruses to alpha/beta interferon-defective mice expressing human CD46 with human-like tissue specificity. Various marker genes were employed, and green fluorescent protein proved to be most informative. Mesothelium and ovarian surface epithelium were remarkably resistant to infection, but infected peritoneal macrophages were present in abundance both in peritoneal lavage fluid and in the greater omentum, where they were heavily concentrated in {"}milky spots{"}. Infected macrophages were also identified outside the peritoneal cavity, along the peritoneal fluid drainage pathway and in the spleen. Thus, diaphragmatic stomata, thoracic lymphatic vessels, and parathymic lymph nodes contained numerous measles-infected cells, as did the marginal zones of the white pulp of the spleen. Splenic marginal zone macrophages were the predominant targets of infection after intravenous administration of oncolytic measles viruses. When measles-infected peritoneal macrophages were adoptively transferred, they did not migrate beyond the confines of the peritoneal cavity, suggesting that, after intraperitoneal virus administration, the positive cells in thoracic lymphatics, parathymic lymph nodes, and spleen are nonmigratory cells transduced in situ by viral particles that have exited from the peritoneal cavity.",
author = "Kah-Whye Peng and Marie Frenzke and Rae Myers and Diane Soeffker and Mary Harvey and Suzanne Greiner and Evanthia Galanis and Roberto Cattaneo and Federspiel, {Mark J} and Russell, {Stephen J}",
year = "2003",
month = "11",
day = "1",
doi = "10.1089/104303403322495070",
language = "English (US)",
volume = "14",
pages = "1565--1577",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "16",

}

TY - JOUR

T1 - Biodistribution of Oncolytic Measles Virus after Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice

AU - Peng, Kah-Whye

AU - Frenzke, Marie

AU - Myers, Rae

AU - Soeffker, Diane

AU - Harvey, Mary

AU - Greiner, Suzanne

AU - Galanis, Evanthia

AU - Cattaneo, Roberto

AU - Federspiel, Mark J

AU - Russell, Stephen J

PY - 2003/11/1

Y1 - 2003/11/1

N2 - In support of a proposed phase I clinical trial, we studied the biodistribution of virus-infected cells after intraperitoneal administration of oncolytic measles viruses to alpha/beta interferon-defective mice expressing human CD46 with human-like tissue specificity. Various marker genes were employed, and green fluorescent protein proved to be most informative. Mesothelium and ovarian surface epithelium were remarkably resistant to infection, but infected peritoneal macrophages were present in abundance both in peritoneal lavage fluid and in the greater omentum, where they were heavily concentrated in "milky spots". Infected macrophages were also identified outside the peritoneal cavity, along the peritoneal fluid drainage pathway and in the spleen. Thus, diaphragmatic stomata, thoracic lymphatic vessels, and parathymic lymph nodes contained numerous measles-infected cells, as did the marginal zones of the white pulp of the spleen. Splenic marginal zone macrophages were the predominant targets of infection after intravenous administration of oncolytic measles viruses. When measles-infected peritoneal macrophages were adoptively transferred, they did not migrate beyond the confines of the peritoneal cavity, suggesting that, after intraperitoneal virus administration, the positive cells in thoracic lymphatics, parathymic lymph nodes, and spleen are nonmigratory cells transduced in situ by viral particles that have exited from the peritoneal cavity.

AB - In support of a proposed phase I clinical trial, we studied the biodistribution of virus-infected cells after intraperitoneal administration of oncolytic measles viruses to alpha/beta interferon-defective mice expressing human CD46 with human-like tissue specificity. Various marker genes were employed, and green fluorescent protein proved to be most informative. Mesothelium and ovarian surface epithelium were remarkably resistant to infection, but infected peritoneal macrophages were present in abundance both in peritoneal lavage fluid and in the greater omentum, where they were heavily concentrated in "milky spots". Infected macrophages were also identified outside the peritoneal cavity, along the peritoneal fluid drainage pathway and in the spleen. Thus, diaphragmatic stomata, thoracic lymphatic vessels, and parathymic lymph nodes contained numerous measles-infected cells, as did the marginal zones of the white pulp of the spleen. Splenic marginal zone macrophages were the predominant targets of infection after intravenous administration of oncolytic measles viruses. When measles-infected peritoneal macrophages were adoptively transferred, they did not migrate beyond the confines of the peritoneal cavity, suggesting that, after intraperitoneal virus administration, the positive cells in thoracic lymphatics, parathymic lymph nodes, and spleen are nonmigratory cells transduced in situ by viral particles that have exited from the peritoneal cavity.

UR - http://www.scopus.com/inward/record.url?scp=10744219926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744219926&partnerID=8YFLogxK

U2 - 10.1089/104303403322495070

DO - 10.1089/104303403322495070

M3 - Article

VL - 14

SP - 1565

EP - 1577

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 16

ER -